# Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers

> **NCT05622825** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Advanced Liver Cancers

## Interventions

- **BIOLOGICAL:** DC-CIK

## Key facts

- **NCT ID:** NCT05622825
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05622825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05622825, "Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05622825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*